Equity Exchange Agreement By and Among BioStem Technologies, Inc. And Andrew Van VurstEquity Exchange Agreement • September 27th, 2024 • Biostem Technologies • Florida
Contract Type FiledSeptember 27th, 2024 Company JurisdictionThis Equity Exchange Agreement (this “Agreement”) is entered into as of March 31, 2022 (the “Closing Date”), by and among BioStem Technologies, Inc., a Florida corporation (the “Company”) and Andrew Van Vurst (“Creditor”). The Company and Creditor may be collectively referred to herein as the “Parties” and individually as a “Party.”
Equity Exchange Agreement By and Among BioStem Technologies, Inc. And Jason MatuszewskiEquity Exchange Agreement • September 27th, 2024 • Biostem Technologies • Florida
Contract Type FiledSeptember 27th, 2024 Company JurisdictionThis Equity Exchange Agreement (this “Agreement”) is entered into as of March 31, 2022 (the “Closing Date”), by and among BioStem Technologies, Inc., a Florida corporation (the “Company”) and Jason Matuszewski (“Creditor”). The Company and Creditor may be collectively referred to herein as the “Parties” and individually as a “Party.”